Sort
82,697 grants matching “vaccine development”
Accelerated molecular probe pipeline
$683,601Gerard A Cangelosi · University Of Washington · U01 · FY2013 · AI
ALLOGENEIC TGF-B ANTISENSE CELL VACCINE FOR LUNG CANCER
$683,587Novarx Corporation · R44 · FY2005 · CA
Resource for NMR Molecular Imaging of Proteins
$683,564University Of California San Diego · P41 · FY2005 · EB
Studies of Inherited Causes of Fungal Susceptability
$683,551Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Administrative Core
$683,546Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2012 · AI
Spatially responsive mass vaccination strategies for urban rabies
$683,466Ricardo Castillo Neyra · University Of Pennsylvania · R01 · FY2022 · AI
Structural and functional characterization of T and NK cell receptors
$683,452Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
HTS for copper-activated inhibitors against MRSA
$683,442Frank Wolschendorf · University Of Alabama At Birmingham · R01 · FY2017 · AI
mRNA-LNPs for ARDS
$683,436Hamideh Parhiz · University Of Pennsylvania · R01 · FY2025 · HL
Development of Novel Antiviral Agents VS West Nile Virus
$683,412Washington University · U01 · FY2004 · AI
Targeting the reproductive interactome of the malaria vector Anopheles gambiae
$683,408Flaminia Catteruccia · Harvard School Of Public Health · R01 · FY2014 · AI
Development and validation of an agent-based model to promote evidence-based control of Taenia solium cysticercosis
$683,379Seth E O'Neal · Oregon Health & Science University · R01 · FY2019 · AI
Influence of Social Media, Social Networks, and Misinformation on Vaccine Acceptance Among Black and Latinx Individuals
$683,352Sean Young · University Of California-Irvine · R01 · FY2024 · MD
Preclinical Assessment of a Multi-Head Electroporation Device for Delivery of Bio
$683,292Connie Schmaljohn · Geneva Foundation · R01 · FY2015 · AI
The development of a recombinant vaccine against human onchocerciasis
$683,255Sara Lustigman · New York Blood Center · R01 · FY2019 · AI
Development of a Recombinant Tetravalent Dengue Vaccine Based on a Subunit Envelo
$683,222Ge Liu · Vaxinnate Corporation · R01 · FY2014 · AI
Identification of serological markers of protection and risk for dengue vaccines and natural infection
$683,213Derek A Cummings · Johns Hopkins University · R01 · FY2024 · AI
MECHANISMS OF CHRONIC HEPATITIS B INFECTION
$683,213Vaccine Research Institute Of San Diego · R01 · FY2004 · AI
Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care
$683,193Michael Paasche-Orlow · Tufts Medical Center · R01 · FY2023 · CA
Genetic Variation and Evolution of Artemisinin Resistance
$683,171Dyann F Wirth · Harvard School Of Public Health · R01 · FY2014 · AI
Human Genetic Dissection of Exit from Latency in Tuberculosis
$683,161Jean-Laurent Casanova · Weill Medical Coll Of Cornell Univ · U19 · FY2017 · AI
Molecular analysis of the mucosal SIVsmm transmission bottleneck
$683,133George M Shaw · University Of Pennsylvania · P01 · FY2012 · AI
Advancement of a Defined, Protective, Live Attenuated Tularemia Vaccine
$683,119Eileen M. Barry · University Of Maryland Baltimore · R01 · FY2013 · AI
Industrialization Core: Production of monoclonal antibodies and product developm
$683,095Larry Zeitlin · Scripps Research Institute, The · U19 · FY2017 · AI
MWCE: Transmission/Pathogenesis of Bioterrorism Agents
$683,088University Of Minnesota Twin Cities · U56 · FY2003 · AI